Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

Market Cap	13.33B +88.4%
Revenue (ttm)	9.30B +32.8%
Net Income	1.26B +8.1%
EPS	7.45 -4.7%
Shares Out	168.76M
PE Ratio	10.60
Forward PE	9.13
Dividend	1.50 (1.90%)
Ex-Dividend Date	Apr 22, 2025

Volume	164,612
Average Volume	198,914
Open	78.47
Previous Close	78.47
Day's Range	78.27 - 79.80
52-Week Range	43.60 - 87.12
Beta	0.57
RSI	47.91
Earnings Date	Mar 2, 2026

About EGX:PHAR

Egyptian International Pharmaceutical Industries Company manufactures and sells pharmaceutical ampoules in Egypt and internationally. The company offers analgesics and antipyretic; analgesics and anti-inflammatory; anti-infective; antihistamine; cardiovascular and metabolic; corticosteroids; gastrointestinal tract; nervous system; ophthalmic; respiratory; topical ointment and cream; vitamins; and miscellaneous products. It also exports its products. Egyptian International Pharmaceutical Industries Company was incorporated in 1980 and is based i...

• Industry: Pharmaceutical Preparations
• Founded: 1980
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: PHAR

Financial Performance

In 2024, EGX:PHAR's revenue was 7.59 billion, an increase of 45.09% compared to the previous year's 5.23 billion. Earnings were 1.10 billion, an increase of 33.25%.